Xeris Biopharma Holdings, Inc. (FRA:2B30)
Germany
· Delayed Price · Currency is EUR 5.47
-0.42 (-7.13%)
At close: Dec 3, 2025
Xeris Biopharma Holdings Market Cap
Xeris Biopharma Holdings has a market cap or net worth of €928.51 million as of December 5, 2025. Its market cap has increased by 119.10% in one year.
Market Cap
928.51M
Enterprise Value
1.07B
Revenue
226.83M
Ranking
n/a
PE Ratio
n/a
Stock Price
€5.47
Market Cap Chart
Since October 6, 2021, Xeris Biopharma Holdings's market cap has increased from 256.47M to 928.51M, an increase of 262.04%. That is a compound annual growth rate of 36.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 928.51M | 90.21% |
| Dec 31, 2024 | 488.15M | 66.23% |
| Dec 29, 2023 | 293.66M | 73.53% |
| Dec 30, 2022 | 169.23M | -47.33% |
| Dec 31, 2021 | 321.29M | 25.28% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 242.06B |
| Siemens Aktiengesellschaft | 175.97B |
| Allianz SE | 138.86B |
| Deutsche Telekom AG | 129.48B |
| Siemens Energy AG | 97.17B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 68.46B |
| Rheinmetall AG | 68.36B |
| Deutsche Bank Aktiengesellschaft | 59.35B |